spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare News Roundup: Oncology

 HSMN NewsFeed - 18 Apr 2019
ViewRay Partners with Leading Canadian Distributor to Bring MRI-guided Radiation Therapy to Canada
Devices Radiology Oncology Distribution
 HSMN NewsFeed - 17 Apr 2019
ViewRay Partners with Largest Independent Distributor in Australia and New Zealand to Bring Benefits of MRI-Guided Radiation Therapy to the Region
Devices Oncology Distribution
 HSMN NewsFeed - 16 Apr 2019
Viracta Receives Orphan Drug Designation from the US FDA for its Lead Epigenetic Drug Candidate Nanatinostat for EBV-Associated Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Apr 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Apr 2019
OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12
Biopharmaceuticals Oncology Drug Delivery
 HSMN NewsFeed - 10 Apr 2019
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Apr 2019
Hoag Radiation Oncology, USA, Selects RayStation as Their New Treatment Planning System
Devices Oncology
 HSMN NewsFeed - 4 Apr 2019
Daiichi Sankyo Provides Update on Ongoing FDA Review for Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Apr 2019
DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company's Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2019
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 2 Apr 2019
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Apr 2019
OncoSec Announces Advanced Therapy Medicinal Product Classification from the EMA for TAVO(TM) in Refractory Metastatic Melanoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 1 Apr 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Mar 2019
Allogeneic CAR-T Specialists TC BioPharm Appoint Prof John Anderson as Scientific and Medical Director
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Mar 2019
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 27 Mar 2019
FDA advances landmark policy changes to modernize mammography services and improve their quality
Devices Radiology Oncology FDA
 HSMN NewsFeed - 25 Mar 2019
Inovio Appoints Global Commercial Leader to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2019
Elekta Unity MR-linac Receives Medical Device License From Health Canada
Devices Radiology Oncology Regulatory
 HSMN NewsFeed - 20 Mar 2019
IceCure Medical Presents Promising Results from First-ever Interventional Radiology Study With Its Next Generation Liquid Nitrogen (LN2) Cryoablation System, ProSense(TM)
Devices Oncology Interventional
 HSMN NewsFeed - 15 Mar 2019
Fujifilm Launches Three New Software Tools For Its ASPIRE Cristalle Digital Mammography System
Devices Radiology Oncology Product Launch
 HSMN NewsFeed - 12 Mar 2019
Onkos Surgical(R) Set to Deliver on Promise of Innovation with 7 New Products Scheduled to Launch in 2019
Devices Surgery Oncology Product Launch
 HSMN NewsFeed - 11 Mar 2019
Alcyone Lifesciences Receives Breakthrough Device Designation from U.S. FDA for the ThecaFlex DRx(TM) System
Devices Neurology Oncology Drug Delivery FDA
 HSMN NewsFeed - 11 Mar 2019
Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India
Devices Oncology
 HSMN NewsFeed - 8 Mar 2019
Elekta Hits Radiotherapy Milestone With 5,000th Linear Accelerator Manufactured
Devices Oncology
 HSMN NewsFeed - 5 Mar 2019
The Oklahoma Proton Center, USA, Selects RayStation as its Treatment Planning System
Devices Oncology
 HSMN NewsFeed - 1 Mar 2019
Rakuten Aspyrian Announces Name Change to Rakuten Medical
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Feb 2019
Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer
Devices Oncology Dermatology Personnel
 HSMN NewsFeed - 27 Feb 2019
Breckenridge Announces Final Approval of its ANDA for Exemestane Tablets (Aromasin(R))
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 27 Feb 2019
Cologuard Helps Screen Two Million People for Colorectal Cancer
Diagnostics Oncology
 HSMN NewsFeed - 27 Feb 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Feb 2019
NW Bio Hires David Innes As Vice President, Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Feb 2019
Thermo Fisher Scientific's Oncomine Dx Target Test Receives Expanded Regulatory Approval in Japan
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 26 Feb 2019
ImaginAb Announces change in management and strengthening of the Board of Directors and the Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Feb 2019
FDA Approves Taiho Oncology's LONSURF(R) (trifluridine/tipiracil) for Adult Patients with Previously Treated Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Feb 2019
Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer
Devices Oncology
Older Oncology stories   Return to NewsFeed  
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.